Chengdu Houhan Technology Co., Ltd. and Beijing Houhong Technology Co., Ltd. agreed to acquire 49.9% stake in Sichuan Huiyu Yueying Pharmaceutical Technology Co., Ltd. from Sichuan Huiyu Pharmaceutical Co., Ltd. for CNY 16.6 million.

Sichuan Huiyu Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of anti-tumor and injection drugs. The Company’s products are mainly anti-tumor chemical injections, including pemetrexed disodium for injection, docetaxel injection, zoledronic acid injection, irinotecan hydrochloride injection, doxorubicin hydrochloride injection liquid and azacitidine for injection. The Company's products are mainly used in the clinical treatment of various adaptive diseases. The Company distributes its products both in the domestic market and to overseas markets.